US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
AU599373B2
(en)
|
1986-03-13 |
1990-07-19 |
Biotechnology Australia Proprietary Limited |
Method of assay of inhibin
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
US4942184A
(en)
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
US5632990A
(en)
|
1988-04-22 |
1997-05-27 |
Cancer Research Campaign Tech. Ltd. |
Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
US5028697A
(en)
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
DE3912638A1
(de)
|
1989-04-18 |
1990-10-31 |
Bayer Ag |
Gentechnologisch hergestellte homologe des alzheimer protease inhibitors, wirtstaemme sowie expressionsvektoren fuer ihre herstellung und ihre verwendung als arzneimittel
|
US5126249A
(en)
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US6475781B1
(en)
|
1990-05-17 |
2002-11-05 |
Dana-Farber Cancer Institute, Inc. |
Trans-dominant suppressor genes for oligomeric proteins
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
GB9017008D0
(en)
|
1990-08-02 |
1990-09-19 |
Erba Carlo Spa |
Process for the enzymatic preparation of basic fibroblast growth factor
|
US6495513B1
(en)
|
1991-03-11 |
2002-12-17 |
Curis, Inc. |
Morphogen-enhanced survival and repair of neural cells
|
US5955444A
(en)
|
1991-08-09 |
1999-09-21 |
Massachusetts Institute Of Technology |
Method of inhibiting abnormal tau hyper phosphorylation in a cell
|
US5627270A
(en)
|
1991-12-13 |
1997-05-06 |
Trustees Of Princeton University |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5204354A
(en)
|
1992-02-14 |
1993-04-20 |
Merck & Co., Inc. |
Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
|
GB9213077D0
(en)
|
1992-06-19 |
1992-08-05 |
Erba Carlo Spa |
Polymerbound taxol derivatives
|
US5807980A
(en)
|
1992-07-13 |
1998-09-15 |
Corvas International, Inc. |
Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex
|
EP0599303A3
(en)
*
|
1992-11-27 |
1998-07-29 |
Takeda Chemical Industries, Ltd. |
Peptide conjugate
|
JPH06228199A
(ja)
*
|
1992-11-27 |
1994-08-16 |
Takeda Chem Ind Ltd |
血液脳関門通過可能なペプチド結合体
|
WO1994019692A1
(en)
|
1993-02-18 |
1994-09-01 |
The General Hospital Corporation |
Alzheimer's disease therapeutics
|
EP0820466A2
(en)
|
1995-04-04 |
1998-01-28 |
Advanced Bioconcept Inc. |
Fluorescent peptides
|
WO1996035788A2
(en)
|
1995-05-08 |
1996-11-14 |
Scios, Inc. |
Kunitz type protease inhibitors
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
AU5908296A
(en)
|
1995-05-31 |
1996-12-24 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for targeted delivery of effector m olecules
|
US5780265A
(en)
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
US5665702A
(en)
|
1995-06-06 |
1997-09-09 |
Biomeasure Incorporated |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
AU6267896A
(en)
|
1995-06-07 |
1996-12-30 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth oftumors
|
BR9708021A
(pt)
|
1996-03-11 |
1999-07-27 |
Bayer Ag |
Proteína substancialmente purificada composição farmacêutica sequência de ácido nucleico isolada vetor de express o de protéina auto-replicante e processos para inibir a atividade de protéinas de serina tratar uma condição e preparar um medicamento de uma proteína
|
EP0966303A2
(en)
|
1996-05-01 |
1999-12-29 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
DE19636889A1
(de)
|
1996-09-11 |
1998-03-12 |
Felix Dr Kratz |
Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
|
EP0932390A1
(en)
|
1996-10-11 |
1999-08-04 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
DE69838544T2
(de)
|
1997-03-04 |
2008-07-24 |
Savient Pharmaceuticals, Inc. |
Isolierung von gewebespezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
|
GB9705903D0
(en)
|
1997-03-21 |
1997-05-07 |
Elliott Gillian D |
VP22 Proteins and uses thereof
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
BR9809138A
(pt)
|
1997-05-21 |
2001-08-28 |
Trustees For The Leland Stanfo |
Conjugado e método para aumentar o transporte de um composto selecionado atravessando uma membrana biológica
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US6475481B2
(en)
|
1997-11-18 |
2002-11-05 |
Canji Inc |
Purging of stem cell products
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
US5981564A
(en)
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
US6703381B1
(en)
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US5922754A
(en)
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
CA2362937C
(en)
|
1999-02-24 |
2011-03-22 |
The Uab Research Foundation |
Taxane derivatives for targeted therapy of cancer
|
DE60006100T2
(de)
*
|
1999-05-17 |
2004-07-01 |
Conjuchem, Inc., Montreal |
Lang wirkende insulinotrope peptide
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
JP2003509488A
(ja)
|
1999-09-24 |
2003-03-11 |
ジェネンテック・インコーポレーテッド |
チロシン誘導体
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
DE19953696A1
(de)
|
1999-11-09 |
2001-05-10 |
Alexander Cherkasky |
Selektive proteolytische Synzyme (SPS)
|
CA2355334A1
(en)
|
2000-10-16 |
2002-04-16 |
Procyon Biopharma Inc. |
Pharmaceutical preparations and methods for inhibiting tumors
|
WO2002043765A2
(en)
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
CZ308214B6
(cs)
|
2000-12-07 |
2020-03-04 |
Eli Lilly And Company |
GLP-1 fúzní proteiny
|
IL157993A0
(en)
|
2001-03-23 |
2004-03-28 |
Napro Biotherapeutics Inc |
Molecular conjugates for use in cancer treatment and methods for the preparation thereof
|
WO2002085923A2
(en)
|
2001-04-19 |
2002-10-31 |
The Scripps Research Institute |
In vivo incorporation of unnatural amino acids
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
EP1554572B1
(en)
|
2001-07-25 |
2009-10-14 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
US7192921B2
(en)
|
2001-11-08 |
2007-03-20 |
The Burnham Institute |
Peptides that home to tumor lymphatic vasculature and methods of using same
|
US20040058865A1
(en)
*
|
2001-11-26 |
2004-03-25 |
Danishefsky Samuel J |
Homing peptide multimers, their preparation and uses
|
JP2005517024A
(ja)
|
2002-02-07 |
2005-06-09 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム |
生物学的障壁を横切る透過を促進し得るアミノ酸配列
|
EP1495045B1
(en)
|
2002-03-29 |
2009-09-02 |
Creagene, Inc. |
Cytoplasmic transduction peptides and uses thereof
|
US6881829B2
(en)
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
AU2003237314B2
(en)
|
2002-05-29 |
2010-03-04 |
Biomarin Pharmaceutical Inc. |
Targeted therapeutic proteins
|
WO2004003145A2
(en)
|
2002-06-28 |
2004-01-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
EP1560931B1
(en)
|
2002-11-14 |
2011-07-27 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20040102369A1
(en)
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
US7319090B2
(en)
|
2002-11-27 |
2008-01-15 |
University Of North Carolina At Chapel Hill |
Methods of treating cerebral ischemia
|
US9221867B2
(en)
*
|
2003-01-06 |
2015-12-29 |
Angiochem Inc. |
Method for transporting a compound across the blood-brain barrier
|
US20040162284A1
(en)
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
EP1615646B2
(en)
|
2003-04-08 |
2022-07-27 |
Progenics Pharmaceuticals, Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
ATE546151T1
(de)
|
2003-04-08 |
2012-03-15 |
Biotempt Bv |
Verwendung von hcg-fragmente enthaltene zusammensetzungen zur mukosalen und oralen anwendung
|
EP2664672A1
(en)
|
2003-04-17 |
2013-11-20 |
Alnylam Pharmaceuticals Inc. |
Modified iRNA agents
|
AU2003286870A1
(en)
|
2003-06-05 |
2005-01-04 |
Salk Institute For Biological Studies |
Targeting polypeptides to the central nervous system
|
EP1638605B1
(en)
|
2003-06-20 |
2014-01-08 |
Raptor Pharmaceutical, Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
AU2004263458B2
(en)
|
2003-08-08 |
2010-06-24 |
Actgen, Inc. |
Polypeptides having brain-localizing activity and uses thereof
|
US20070275871A1
(en)
|
2003-08-28 |
2007-11-29 |
Biorexis Technology, Inc. |
Epo Mimetic Peptides and Fusion Proteins
|
US20050058702A1
(en)
|
2003-09-17 |
2005-03-17 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
US20050208095A1
(en)
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
US7208174B2
(en)
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
US7638299B2
(en)
|
2004-07-21 |
2009-12-29 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
NZ553224A
(en)
|
2004-07-26 |
2009-05-31 |
Asterion Ltd |
Linkers
|
EP1799826B1
(en)
|
2004-09-29 |
2009-08-12 |
Children's Memorial Hospital |
siRNA-MEDIATED GENE SILENCING OF ALPHA SYNUCLEIN
|
US9002652B1
(en)
|
2005-01-27 |
2015-04-07 |
Institute For Systems Biology |
Methods for identifying and using organ-specific proteins in blood
|
US20090016959A1
(en)
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
EP2360258B1
(en)
|
2005-02-18 |
2014-10-08 |
Angiochem Inc. |
Aprotinin polypeptides for transporting a compound across the blood-brain barrier
|
CN105288630A
(zh)
|
2005-02-18 |
2016-02-03 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
WO2006108052A2
(en)
|
2005-04-06 |
2006-10-12 |
Genzyme Corporation |
Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
|
US20090246211A1
(en)
|
2005-05-12 |
2009-10-01 |
Henri John T |
Molecular constructs suitable for targeted conjugates
|
WO2006138343A2
(en)
|
2005-06-14 |
2006-12-28 |
Raptor Pharmaceutical Inc. |
Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof
|
ES2424242T3
(es)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc. |
Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
|
EP1904642A4
(en)
|
2005-07-19 |
2008-11-26 |
Univ Illinois |
TRANSPORT AGENTS USEFUL FOR CROSSING THE HEMATO-ENCEPHALIC BARRIER AND FOR PENETRATING IN CANCER CELLS OF THE BRAIN, METHODS OF USING THE SAME
|
GB0517092D0
(en)
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
JP2009507852A
(ja)
|
2005-09-08 |
2009-02-26 |
エムディーアールエヌエー,インコーポレイテッド |
リボ核酸の細胞への送達用医薬組成物
|
US9062126B2
(en)
|
2005-09-16 |
2015-06-23 |
Raptor Pharmaceuticals Inc. |
Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
|
EP1996220B2
(en)
*
|
2006-03-06 |
2023-08-16 |
Amunix Operating Inc. |
Unstructured recombinant polymers and uses thereof
|
US8053569B2
(en)
|
2005-10-07 |
2011-11-08 |
Armagen Technologies, Inc. |
Nucleic acids encoding and methods of producing fusion proteins
|
WO2007053696A2
(en)
|
2005-11-01 |
2007-05-10 |
Alnylam Pharmaceuticals, Inc. |
Rnai inhibition of influenza virus replication
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
US8290433B2
(en)
|
2007-11-14 |
2012-10-16 |
Blaze Mobile, Inc. |
Method and system for securing transactions made through a mobile communication device
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
US7477504B1
(en)
|
2006-03-13 |
2009-01-13 |
C.P.D. Technologies, Inc. |
Versatile stun glove
|
SI2177536T1
(sl)
*
|
2006-03-30 |
2014-09-30 |
Glaxo Group Limited |
Protitelesa proti amiloidnemu peptidu beta
|
EP2043696B1
(en)
|
2006-07-13 |
2015-02-25 |
Burnham Institute for Medical Research |
Methods and compositions for targeting gc1qr/p32
|
AU2007278994B2
(en)
|
2006-07-24 |
2013-08-15 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
EP2063905B1
(en)
|
2006-09-18 |
2014-07-30 |
Raptor Pharmaceutical Inc |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
EP2074142A4
(en)
|
2006-10-19 |
2010-10-27 |
Angiochem Inc |
COMPOUNDS FOR STIMULATING THE FUNCTION OF P-GLYCOPROTEIN AND APPLICATIONS THEREOF
|
WO2008069876A2
(en)
|
2006-10-27 |
2008-06-12 |
University Of Kentucky Research Foundation |
Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation
|
US9399675B2
(en)
|
2007-02-28 |
2016-07-26 |
The Board Of Regents Of The University Of Oklahoma |
Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
|
MX2009010148A
(es)
|
2007-03-21 |
2009-12-01 |
Raptor Pharmaceutical Inc |
Peptidos ciclicos de proteinas receptor-asociadas (rap).
|
CA2688344C
(en)
*
|
2007-05-29 |
2019-09-03 |
Angiochem, Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
US8802631B2
(en)
|
2007-09-17 |
2014-08-12 |
Ludwig Institute For Cancer Research Ltd. |
Peptides and methods for the treatment of gliomas and other cancers
|
NZ584048A
(en)
|
2007-10-02 |
2012-08-31 |
Marina Biotech Inc |
Lipopeptides for delivery of nucleic acids
|
WO2009070597A2
(en)
*
|
2007-11-26 |
2009-06-04 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of gdnf to the cns
|
RU2010129761A
(ru)
*
|
2007-12-20 |
2012-01-27 |
Ангиочем Инк. (Ca) |
Конъюгаты полипептидов с нуклеиновыми кислотами и их применение
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
EP2250278B1
(en)
|
2008-02-21 |
2023-04-05 |
Burnham Institute for Medical Research |
Methods and compositions related to peptides and proteins with c-terminal elements
|
CA2721019C
(en)
|
2008-04-18 |
2015-09-15 |
Angiochem Inc. |
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
|
WO2010006239A2
(en)
|
2008-07-10 |
2010-01-14 |
The Board Of Trustees Of The University Of Illinois |
Regulation of apoptosis by neural specific splice variants of ig20
|
US8828925B2
(en)
|
2008-10-15 |
2014-09-09 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
MX2011004017A
(es)
*
|
2008-10-15 |
2011-06-24 |
Angiochem Inc |
Conjugados de agonistas glp-1 y usos de los mismos.
|
JP2012510797A
(ja)
|
2008-12-05 |
2012-05-17 |
アンジオケム インコーポレーテッド |
レプチンおよびレプチン類似体コンジュゲートならびにそれらの使用
|
CA2745524C
(en)
|
2008-12-05 |
2020-06-09 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
CA2745499A1
(en)
*
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Peptide therapeutic conjugates and uses thereof
|
JP2012512185A
(ja)
|
2008-12-17 |
2012-05-31 |
アンジオケム インコーポレーテッド |
膜1型マトリックス金属タンパク質阻害剤およびその使用
|
US9173891B2
(en)
|
2009-04-20 |
2015-11-03 |
Angiochem, Inc. |
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
|
US20100284921A1
(en)
|
2009-05-08 |
2010-11-11 |
Temple University - Of The Commonwealth System Of Higher Education |
Targeted nanoparticles for intracellular cancer therapy
|
CN102497870A
(zh)
|
2009-06-03 |
2012-06-13 |
戴瑟纳制药公司 |
肽-dicer底物试剂及其特异性抑制基因表达的方法
|
MX2011013258A
(es)
|
2009-06-11 |
2012-02-28 |
Angiochem Inc |
Proteinas de fusion para entrega de gdnf y bdnf al sistema nervioso central.
|
IN2012DN00248A
(US07119074-20061010-C00048.png)
|
2009-07-02 |
2015-05-01 |
Angiochem Inc |
|
WO2011008823A2
(en)
|
2009-07-14 |
2011-01-20 |
Mayo Foundation For Medical Education And Research |
Peptide-mediated non-covalent delivery of active agents across the blood brain barrier
|
EP2486061A4
(en)
|
2009-10-06 |
2013-08-28 |
Angiochem Inc |
COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTICS
|
US9095541B2
(en)
|
2009-11-24 |
2015-08-04 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
EP4201402A1
(en)
|
2010-03-08 |
2023-06-28 |
Sloan-Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011119608A1
(en)
|
2010-03-26 |
2011-09-29 |
University Of Tennessee Research Foundation |
Peptides that specifically target amyloid deposits
|
CA2796215C
(en)
|
2010-04-14 |
2021-05-18 |
National Research Council Of Canada |
Compositions and methods for brain delivery of analgesic peptides
|
WO2011153642A1
(en)
|
2010-06-10 |
2011-12-15 |
Angiochem Inc. |
Leptin and leptin analog conjugates and fusion proteins and uses thereof
|
CN103080125A
(zh)
|
2010-07-02 |
2013-05-01 |
安吉奥开米公司 |
用于治疗性结合物的短且含d氨基酸的多肽及其使用
|
US8218280B2
(en)
|
2010-07-08 |
2012-07-10 |
Schneider Electric USA, Inc. |
Secondary thermal sensor for primary conductors
|
AU2011286407A1
(en)
|
2010-08-06 |
2013-02-21 |
Amgen |
Use of HER3 binding agents in prostate treatment
|
CN102406949B
(zh)
|
2010-09-21 |
2013-05-29 |
复旦大学 |
一种靶向示踪的多模式诊断纳米影像药物
|
WO2012037687A1
(en)
|
2010-09-23 |
2012-03-29 |
Angiochem Inc. |
Therapeutic polypeptides and uses thereof
|
EP2637669A4
(en)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and their use
|
RU2018102375A
(ru)
|
2010-11-18 |
2019-02-21 |
Зе Дженерал Хоспитал Корпорейшен |
Новые композиции и применения антигипертензивных средств для терапии рака
|
CN102552928A
(zh)
|
2010-12-19 |
2012-07-11 |
复旦大学 |
一种治疗脑部肿瘤的双级靶向递药系统及其制备方法
|
NZ612909A
(en)
|
2011-01-10 |
2015-09-25 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
CN102614105A
(zh)
|
2011-01-28 |
2012-08-01 |
复旦大学 |
一种脑靶向载两性霉素b聚合物胶束给药系统
|
EP2680820B1
(en)
|
2011-03-01 |
2022-11-02 |
2-BBB Medicines B.V. |
Advanced active liposomal loading of poorly water-soluble substances
|
CA2831392C
(en)
|
2011-03-28 |
2020-04-28 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
WO2012138694A2
(en)
|
2011-04-07 |
2012-10-11 |
Emory University |
Compositions comprising saccharide binding moieties and methods for targeted therapy
|
RU2013154422A
(ru)
|
2011-05-09 |
2015-06-20 |
Институт Кимик Де Саррия |
Полимерные наночастицы, предназначенные для доставки лекарственных средств
|
WO2013004716A1
(en)
|
2011-07-04 |
2013-01-10 |
Universität Basel |
Peptide beads
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TWI565709B
(zh)
|
2011-07-19 |
2017-01-11 |
英菲尼提製藥股份有限公司 |
雜環化合物及其用途
|
EA027970B1
(ru)
|
2011-08-11 |
2017-09-29 |
ИНТЕЛЛАЙКИН, ЭлЭлСи |
Полиморфы ингибитора киназы
|
AR091790A1
(es)
|
2011-08-29 |
2015-03-04 |
Infinity Pharmaceuticals Inc |
Derivados de isoquinolin-1-ona y sus usos
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
WO2013056096A1
(en)
|
2011-10-13 |
2013-04-18 |
Angiochem Inc. |
Polypeptide-opioid conjugates and uses thereof
|
NZ747501A
(en)
|
2011-10-27 |
2020-05-29 |
Massachusetts Inst Technology |
Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
|
JP6078076B2
(ja)
|
2011-11-11 |
2017-02-08 |
インテリカイン, エルエルシー |
キナーゼ阻害剤多形体
|
AU2012344700A1
(en)
|
2011-12-01 |
2014-06-19 |
Angiochem Inc. |
Targeted iduronate-2-sulfatase compounds
|
WO2013078564A2
(en)
|
2011-12-01 |
2013-06-06 |
Angiochem Inc. |
Targeted lysosomal enzyme compounds
|
US9844598B2
(en)
|
2011-12-13 |
2017-12-19 |
Engeneic Molecular Delivery Pty Ltd |
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
|
BR112014014599A2
(pt)
|
2011-12-16 |
2017-06-13 |
Massachusetts Inst Technology |
polímeros de alfa-aminoamidina e uso dos mesmos
|
WO2013120107A1
(en)
|
2012-02-09 |
2013-08-15 |
University Of Rochester |
Methods and compositions for treating a subject to inhibit hearing loss
|
EP2819686A4
(en)
|
2012-03-02 |
2016-05-25 |
Icahn School Med Mount Sinai |
PROTHYMOSIN ALPHA VARIANTS AND METHODS OF USE
|
SI2833905T1
(en)
|
2012-04-04 |
2018-08-31 |
Halozyme, Inc. |
Combination therapy with hyaluronidase and tumane-directed taxane
|
ES2905359T3
(es)
|
2012-04-26 |
2022-04-08 |
Univ Yale |
Moléculas de suministro de fármacos citotóxicos dirigidas al VIH (CDM-H), actividad citotóxica contra el virus de la inmunodeficiencia humana y métodos de uso
|
WO2013185235A1
(en)
|
2012-06-15 |
2013-12-19 |
Angiochem Inc. |
Targeted iduronidase compounds
|